Dexamethasone and nonsteroidal anti-inflammatory agents in the treatment of bacterial meningitis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

It has been shown in experimental models of bacterial meningitis that bacterial cell-wall components produce an inflammatory response in the subarachnoid space, probably by stimulating the release of inflammatory cytokines, such as tumor necrosis factor, interleukin-1, and prostaglandins. Interleukin-1 increases the concentration of prostaglandin E2 and leukotriene B4, metabolites of arachidonic acid, which are potent mediators of inflammation. Steroidal and nonsteroidal anti-inflammatory agents decrease the formation of these metabolites and minimize the damage to the blood-brain barrier. There is also evidence that anti-inflammatory agents decrease cerebral edema in bacterial meningitis. The results of clinical trials in patients with bacterial meningitis demonstrate that dexamethasone can prevent sensorineural hearing loss and reduce mortality, without interfering with the antimicrobial action of antibiotics.

Original languageEnglish
Pages (from-to)290-296
Number of pages7
JournalClinical Therapeutics
Volume12
Issue number4
StatePublished - 1990

Fingerprint

Bacterial Meningitides
Non-Steroidal Anti-Inflammatory Agents
Dexamethasone
Interleukin-1
Inflammation Mediators
Subarachnoid Space
Leukotriene B4
Sensorineural Hearing Loss
Brain Edema
Cellular Structures
Blood-Brain Barrier
Dinoprostone
Arachidonic Acid
Cell Wall
Prostaglandins
Anti-Inflammatory Agents
Theoretical Models
Therapeutics
Tumor Necrosis Factor-alpha
Clinical Trials

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dexamethasone and nonsteroidal anti-inflammatory agents in the treatment of bacterial meningitis. / Roos, Karen.

In: Clinical Therapeutics, Vol. 12, No. 4, 1990, p. 290-296.

Research output: Contribution to journalArticle

@article{393cf7910ce94a72bfd8424db904a577,
title = "Dexamethasone and nonsteroidal anti-inflammatory agents in the treatment of bacterial meningitis",
abstract = "It has been shown in experimental models of bacterial meningitis that bacterial cell-wall components produce an inflammatory response in the subarachnoid space, probably by stimulating the release of inflammatory cytokines, such as tumor necrosis factor, interleukin-1, and prostaglandins. Interleukin-1 increases the concentration of prostaglandin E2 and leukotriene B4, metabolites of arachidonic acid, which are potent mediators of inflammation. Steroidal and nonsteroidal anti-inflammatory agents decrease the formation of these metabolites and minimize the damage to the blood-brain barrier. There is also evidence that anti-inflammatory agents decrease cerebral edema in bacterial meningitis. The results of clinical trials in patients with bacterial meningitis demonstrate that dexamethasone can prevent sensorineural hearing loss and reduce mortality, without interfering with the antimicrobial action of antibiotics.",
author = "Karen Roos",
year = "1990",
language = "English",
volume = "12",
pages = "290--296",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "4",

}

TY - JOUR

T1 - Dexamethasone and nonsteroidal anti-inflammatory agents in the treatment of bacterial meningitis

AU - Roos, Karen

PY - 1990

Y1 - 1990

N2 - It has been shown in experimental models of bacterial meningitis that bacterial cell-wall components produce an inflammatory response in the subarachnoid space, probably by stimulating the release of inflammatory cytokines, such as tumor necrosis factor, interleukin-1, and prostaglandins. Interleukin-1 increases the concentration of prostaglandin E2 and leukotriene B4, metabolites of arachidonic acid, which are potent mediators of inflammation. Steroidal and nonsteroidal anti-inflammatory agents decrease the formation of these metabolites and minimize the damage to the blood-brain barrier. There is also evidence that anti-inflammatory agents decrease cerebral edema in bacterial meningitis. The results of clinical trials in patients with bacterial meningitis demonstrate that dexamethasone can prevent sensorineural hearing loss and reduce mortality, without interfering with the antimicrobial action of antibiotics.

AB - It has been shown in experimental models of bacterial meningitis that bacterial cell-wall components produce an inflammatory response in the subarachnoid space, probably by stimulating the release of inflammatory cytokines, such as tumor necrosis factor, interleukin-1, and prostaglandins. Interleukin-1 increases the concentration of prostaglandin E2 and leukotriene B4, metabolites of arachidonic acid, which are potent mediators of inflammation. Steroidal and nonsteroidal anti-inflammatory agents decrease the formation of these metabolites and minimize the damage to the blood-brain barrier. There is also evidence that anti-inflammatory agents decrease cerebral edema in bacterial meningitis. The results of clinical trials in patients with bacterial meningitis demonstrate that dexamethasone can prevent sensorineural hearing loss and reduce mortality, without interfering with the antimicrobial action of antibiotics.

UR - http://www.scopus.com/inward/record.url?scp=0025088393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025088393&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 290

EP - 296

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 4

ER -